Moreover, the depletion of CD5L shows cardiac effects, such as decreased systolic dysfunction, a decreased incidence of cardiac rupture, and reduction of the infarct size during the acute phase after myocardial infarction, in turn resulting in improved survival rates [28, 29]. The gene discussed is CD5L; the disease is myocardial infarction.